HOUSTON AIDS RESEARCH TEAM (HART)

休斯顿艾滋病研究小组（哈特）由一组初级保健提供者组成，他们为休斯顿的大多数艾滋病毒感染者提供服务。 哈特由汤姆斯街诊所（德克萨斯大学休斯顿医学院和贝勒医学院）、退伍军人事务医疗中心（贝勒医学院）和休斯顿临床研究网络、蒙特罗斯诊所分部组成。 哈特的使命是在初级保健环境中进行高质量的临床研究，以回答以前没有参加过艾滋病毒相关临床试验或在艾滋病毒相关临床试验中代表性不足的人群的临床相关问题。 哈特的目标是：在整个资助过程中的任何给定时间，招募至少250名可评估的受试者参加CPCRA方案。 协助制定方案，其中包括哈特研究人员、初级保健提供者、社区咨询委员会成员以及休斯顿两所医学院（德克萨斯大学休斯顿分校和贝勒医学院）的HIV/AIDS研究人员的意见。发展和保持一支热情的研究团队，致力于高质量的研究工作。 加强和维护我们当前的质量管理计划，以确保最高标准的数据收集、不良反应报告、监管程序合规性和研究参与者的保密性。 遵守FDA法规和AIDS部门的政策和规程，以便订购、储存、分发和记录研究药物。 参加CPCRA小组会议，以便与CPCRA其他单位和艾滋病司的研究人员和研究成员进行沟通，以制定新的方案，评估现有方案，并更新艾滋病毒的研究进展。 在哈特和CPCRA工作人员、艾滋病部门成员以及CPCRA运营、统计和现场监测中心之间建立友好的工作关系。 在地方，国家和国际会议上展示CPCRA的研究成果，并在同行评审的期刊上发表。 促进和维护哈特与地方、国家和国际研究团体之间的现有合作。

The Houston AIDS Research Team (HART) consists of a group of primary care providers who serve the majority of HIV-infected individuals in Houston. HART comprises Thoms Street Clinic (The University of Texas Medical School at Houston, and Baylor College of Medicine), Veterans Affairs Medical Center (Baylor College of Medicine), and Houston Clinical Research Network, Division of Montrose Clinic. The mission of HART is to conduct high-quality clinical research in primary care settings in order to answer clinically relevant questions in populations who have not previously participated or have been underrepresented in HIV- related clinical trials. HART goals are to: Enroll and have at least 250 evaluable subjects in CPCRA protocols at any given time throughout the course of this grant. Assist in the development of protocols with input from HART investigators, primary care providers, members of the community advisory board, and researchers on HIV/AIDS from the two medical schools in Houston (The University of Texas-Houston and Baylor College of Medicine). Develop and maintain an enthusiastic research team staff dedicated to the performance of high-quality research. Enhance and maintain our current quality management plan to ensure the highest standard of data collection, adverse experience reporting, regulatory procedure compliance, and study participants' confidentiality. Comply with FDA regulations and Division of AIDS policies and procedures for ordering, storing, dispensing, and recording study drugs. Attend CPCRA group meetings in order to communicate with investigators and research members from other CPCRA units and the Division of AIDS to develop new protocols, evaluate current protocols, and update research progress on HIV. Establish a cordial working relationship between HART and CPCRA staff, Division of AIDS members, and CPCRA Operations, Statistical, and Site Monitoring centers. Present CPCRA research results at local, national, and international meeting, and publish them in peer-reviewed journals. Promote and maintain the current collaboration between HART and the local, national, and international research communities.